Erbe Apc3
Payments companies reported to CMS as associated with Erbe Apc3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Erbe Apc3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Erbe Apc3
These are the largest totals companies reported as associated with Erbe Apc3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Dougherty | Raleigh, NC | Gastroenterology (Internal Medicine) | $142.66 |
| Mohsen Pourmorteza | Columbia, SC | Gastroenterology (Internal Medicine) | $142.66 |
| Tanvir Haque | Raleigh, NC | Gastroenterology (Internal Medicine) | $142.66 |
| Kenneth Kohagen | Raleigh, NC | Gastroenterology (Internal Medicine) | $142.66 |
| Zoe Post | Chicago, IL | Gastroenterology (Internal Medicine) | $104.00 |
| Jaya Vasudevan | Austin, TX | Internal Medicine | $80.77 |
| Peter Stawinski | San Antonio, TX | Hospitalist | $80.77 |
| Omer Junaidi | San Antonio, TX | Transplant Hepatology | $80.77 |
| Anoop Prabhu | Columbus, OH | Gastroenterology (Internal Medicine) | $75.00 |
| Michael Moore | West Seneca, NY | Gastroenterology (Internal Medicine) | $75.00 |
Prescribed Erbe Apc3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.